Article
Catecholaminergic polymorphic ventricular tachycardia in children: analysis of therapeutic strategies and outcomes from an international multicenter registry.
Circulation. Arrhythmia and electrophysiology - 1 Jun 2015
Roston Thomas M, Vinocur Jeffrey M, Maginot Kathleen R, Mohammed Saira, Salerno Jack C, Etheridge Susan P, Cohen Mitchell, Hamilton Robert M, Pflaumer Andreas, Kanter Ronald J, Potts James E, LaPage Martin J, Collins Kathryn K, Gebauer Roman A, Temple Joel D, Batra Anjan S, Erickson Christopher, Miszczak-Knecht Maria, Kubuš Peter, Bar-Cohen Yaniv, Kantoch Michal, Thomas Vincent C, Hessling Gabriele, Anderson Chris, Young Ming-Lon, Cabrera Ortega Michel, Lau Yung R, Johnsrude Christopher L, Fournier Anne, Kannankeril Prince J, Sanatani Shubhayan
Abstract excerpt
BACKGROUND: Catecholaminergic polymorphic ventricular tachycardia is an uncommon, potentially lethal, ion channelopathy. Standard therapies have high failure rates and little is known about treatment in children. Newer options such as flecainide and left cardiac sympathetic denervation are not well validated. We sought to define treatment outcomes in children with catecholaminergic polymorphic ventricular...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
